Reduce the Incidence of Chronic Cancer-Related Lymphedema | ImpediMed

Reduce the Incidence of Chronic Cancer-Related Lymphedema

A Comprehensive Look at New Data, Practice Economics and Why L-Dex® is the Next Primary Vital Sign®

Presenters:
Dr. Chirag Shah, Director of Breast Cancer Radiation Oncology, Cleveland Clinic
Dr. Sheri Prentiss, Surgeon Advisory Board Member, Founder, LIVE Today Foundation

Watch Webinar

Webinar Overview

Join Dr. Chirag Shah, Director of Breast Radiation Oncology and Clinical Research, Department of Radiation Oncology at the Cleveland Clinic review the latest clinical data to significantly reduce chronic breast cancer related lymphedema (BCRL).

Dr. Shah will be joined by Dr. Sheri Prentiss who will share her personal journey with breast cancer and lymphedema diagnosis. In addition, the discussion will include the economics of implementing a lymphedema prevention program and overall impact of preventing subclinical BCRL to improve patient care and quality of life. This didactic session will conclude with live Q&A.

Key Takeaways:

  • Understand the latest data supporting lymphedema prevention utilizing L-Dex (the next primary vital sign)
  • The economic impact of implementing a lymphedema prevention program in your practice
  • Learn the five steps you can take during Lymphedema Awareness Month and help cancer patients avoid lymphedemaRegister Today!

Watch Webinar

Health is Fluid Webinar Series

Meet Our Presenters

Dr. Chirag Shah, Director of Breast Cancer Radiation Oncology, Cleveland Clinic

Dr. Chirag Shah, Director of Breast Cancer Radiation Oncology, Cleveland Clinic

Dr. Shah is the Director of Breast Cancer Radiation Oncology and Director of Clinical Research, Department of Radiation Oncology at Cleveland Clinic. Dr. Shah received his Bachelor’s degree from Youngstown State University and his Medical degree from Northeast Ohio Medical University. He completed his internship, and residency at William Beaumont Hospital from 2007 to 2012 and joined the Cleveland Clinic Staff in 2015. Dr. Shah serves as a reviewer for various medical journals and is a member of various medical societies. His primary research interests are breast cancer, and innovative radiation treatment schedules as well as lymphedema. He has participated in numerous in-house, pharmaceutical and cooperative group trials.

Dr. Sheri Prentiss, Surgeon Advisory Board Member, Founder, LIVE Today Foundation

Dr. Sheri Prentiss, Surgeon Advisory Board Member, Founder, LIVE Today Foundation

Dr. Sheri is a board certified occupational & environmental medicine physician, public health expert, a breast cancer survivor, and a lymphedema patient. She is a force for change in health care, teaching practitioners to transform their health care delivery thereby improving the patient experience. She founded her own nonprofit organization, the LIVE Today Foundation, an organization that enhances the quality of life for breast cancer patients and survivors, especially those who suffer from lymphedema. The organization contributes to the health and well-being of its recipients by providing much needed and medically necessary compression garments.

Impedimed SOZO image

Learn More About SOZO®

A single SOZO® reading allows clinicians across multiple specialities to provide individualized proactive care that can help improve patient outcomes.

Fluid Analysis for Secondary Lymphedema

Request Demo